Canada Life’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-717,846
| Closed | -$71.4M | – | 2794 |
|
|
2019
Q3 | $71.4M | Buy |
717,846
+71,535
| +11% | +$6.8M | 0.17% | 142 |
|
|
2019
Q2 | $59.7M | Sell |
646,311
-25,003
| -4% | -$2.37M | 0.14% | 155 |
|
|
2019
Q1 | $63.2M | Buy |
671,314
+122,234
| +22% | +$10.7M | 0.17% | 143 |
|
|
2018
Q4 | $33.8M | Buy |
549,080
+10,639
| +2% | +$785K | 0.1% | 216 |
|
|
2018
Q3 | $48.2M | Sell |
538,441
-126,465
| -19% | -$11.2M | 0.11% | 181 |
|
|
2018
Q2 | $52.8M | Sell |
664,906
-19,539
| -3% | -$1.62M | 0.12% | 174 |
|
|
2018
Q1 | $61.1M | Sell |
684,445
-50,469
| -7% | -$4.84M | 0.15% | 161 |
|
|
2017
Q4 | $76.6M | Sell |
734,914
-26
| -0% | -$2.93K | 0.18% | 121 |
|
|
2017
Q3 | $105M | Sell |
734,940
-31,960
| -4% | -$4.35M | 0.26% | 85 |
|
|
2017
Q2 | $99.4M | Buy |
766,900
+178,797
| +30% | +$21.9M | 0.27% | 79 |
|
|
2017
Q1 | $73.1M | Sell |
588,103
-30,455
| -5% | -$3.64M | 0.2% | 115 |
|
|
2016
Q4 | $71.8M | Sell |
618,558
-32,881
| -5% | -$3.66M | 0.2% | 114 |
|
|
2016
Q3 | $68.1M | Buy |
651,439
+69,618
| +12% | +$7.53M | 0.2% | 115 |
|
|
2016
Q2 | $57.3M | Buy |
581,821
+131,071
| +29% | +$13.6M | 0.17% | 133 |
|
|
2016
Q1 | $45.1M | Sell |
450,750
-79,787
| -15% | -$8.22M | 0.16% | 143 |
|
|
2015
Q4 | $63.6M | Buy |
530,537
+22
| +0% | +$2.54K | 0.24% | 100 |
|
|
2015
Q3 | $57.4M | Sell |
530,515
-206,287
| -28% | -$25.6M | 0.23% | 101 |
|
|
2015
Q2 | $85.2M | Sell |
736,802
-135,784
| -16% | -$15.5M | 0.29% | 79 |
|
|
2015
Q1 | $100M | Sell |
872,586
-10,481
| -1% | -$1.25M | 0.34% | 70 |
|
|
2014
Q4 | $98.8M | Sell |
883,067
-27,312
| -3% | -$2.88M | 0.33% | 73 |
|
|
2014
Q3 | $86.4M | Buy |
910,379
+15,275
| +2% | +$1.38M | 0.29% | 79 |
|
|
2014
Q2 | $76.7M | Buy |
895,104
+18,130
| +2% | +$1.38M | 0.25% | 98 |
|
|
2014
Q1 | $60.9M | Buy |
876,974
+63,408
| +8% | +$5.02M | 0.21% | 105 |
|
|
2013
Q4 | $69M | Sell |
813,566
-149,926
| -16% | -$11.9M | 0.24% | 89 |
|
|
2013
Q3 | $74.1M | Buy |
963,492
+365,990
| +61% | +$25.6M | 0.29% | 75 |
|
|
2013
Q2 | $35M | Buy |
+597,502
| New | +$36M | 0.23% | 89 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Canada Life's CELG Position: Q4 2019 in Review
Canada Life sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 717,846 shares — an estimated $71.4M sold.
Canada Life first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $105M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Canada Life reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Canada Life sold 717,846 Celgene Corp shares in Q4 2019, an estimated $71.4M.
- Canada Life first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Canada Life's Celgene Corp position peaked at $105M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Canada Life's 13F filing for Q4 2019, filed 11 Feb 2020.